Premedication With Oral Midazolam in Patients Undergoing Rigid Cystoscopy: A Randomized, Double-blind, Placebo-controlled Trial

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-09-30

Study Completion Date

2006-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the efficacy of oral midazolam for patients undergoing rigid cystoscopy in:

1. relieving patient's anxiety and improving satisfaction
2. reducing procedure-related pain
3. facilitating the diagnostic and therapeutic interventions during rigid cystoscopy

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI Endoscopy

NCT00869440

Procedural Sedation Endoscopy

COMPLETED PHASE2

Bladder Irrigation 0.05% Lidocaine Decreases Postoperative CRBD

NCT04133571

Bladder Discomfort

UNKNOWN NA

Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures

NCT01756651

Other Acute Pain Pain Experienced During Cystoscopy

COMPLETED PHASE1

Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation

NCT01438931

Sedation

COMPLETED PHASE3

Assessing the Effectiveness of Midazolam Premedication

NCT03325335

Midazolam Premedication Anxiety Preoperative Premedication

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cystoscopy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Midazolam

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Elective rigid cystoscopy
* Either diagnostic or therapeutic
* Age between 18 to 80

Exclusion Criteria

* Patients with allergy to midazolam or other benzodiazepine groups
* Pregnancy
* Emergency rigid cystoscopy
* ASA class 3 or above
* Patients on psychiatric medications
* Alcoholics

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No